Choice of immunosuppression influences cytomegalovirus DNAemia in cynomolgus monkey (Macaca fascicularis) islet allograft recipients

Cell Transplantation

Volumn 19, Issue 12, 2010, Pages 1547-1561

  Han, Dongmei ^a   Berman, Dora M ^a   Willman, Melissa ^a   Buchwald, Peter ^a   Rothen, Daniel ^a   Kenyon, Norman M ^a   Kenyon, Norma S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cytomegalovirus; Immunosuppression; Infection; Nonhuman primates; Transplantation

Indexed keywords

CD20 ANTIGEN; CYCLOPHOSPHAMIDE; DACLIZUMAB; FLUDARABINE; GANCICLOVIR; LEXIDRONAM SAMARIUM SM 153; MONOCLONAL ANTIBODY IDEC 131; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR; VIRUS DNA;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOMEGALOVIRUS DNAEMIA; DIABETES MELLITUS; DISEASE DURATION; DISEASE SEVERITY; DNA VIRUS INFECTION; GRAFT RECIPIENT; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MACACA FASCICULARIS; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; T CELL DEPLETION;

ANALGESICS, NON-NARCOTIC; ANIMALS; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; DNA, VIRAL; GANCICLOVIR; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS TRANSPLANTATION; LEUKOCYTES; MACACA FASCICULARIS; ORGANOMETALLIC COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; RETROSPECTIVE STUDIES; SIROLIMUS; T-LYMPHOCYTES; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS; VIDARABINE;

ANIMALIA; CYTOMEGALOVIRUS; MACACA FASCICULARIS; PRIMATES;

EID: 79951821946     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X513973     Document Type: Article

References (59)

1. Adams, A. B.; Shirasugi, N.; Jones, T. R.; Durham, M. M.; Strobert, E. A.; Cowan, S.; Rees, P.; Hendrix, R.; Price, K.; Kenyon, N. S.; Hagerty, D.; Townsend, R.; Hollenbaugh, D.; Pearson, T. C.; Larsen, C. P. Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival. J. Immunol. 174(1):542-550; 2005.
2. Alford, C.; Britt, W. J. Cytomegalovirus. In: Roizman, B.; Whitley, R. J.; Lopez, C., eds. The human herpes viruses. New York: Raven Press, Ltd.; 1993:227-255.
3. Alford, C. A.; Stagno, S.; Pass, R. F.; Britt, W. J. Congenital and perinatal cytomegalovirus infections. Rev. Infect. Dis. 12(Suppl. 7):S745-753; 1990.
4. Asher, D. M.; Gibbs, Jr., C. J.; Lang, D. J.; Gajdusek, D. C.; Chanock, R. M. Persistent shedding of cytomegalovirus in the urine of healthy rhesus monkeys. Proc. Soc. Exp. Biol. Med. 145(3):794-801; 1974.
5. Barry, P. A.; Lockridge, K. M.; Salamat, S.; Tinling, S. P.; Yue, Y.; Zhou, S. S.; Gospe, Jr., S. M.; Britt, W. J.; Tarantal, A. F. Nonhuman primate models of intrauterine cytomegalovirus infection. ILAR J. 47(1):49-64; 2006.
6. Barshes, N. R.; Lee, T. C.; Brunicardi, F. C.; Mote, A.; Schock, A. P.; Alejandro, R.; Ricordi, C.; Goss, J. A. Lack of cytomegalovirus transmission after pancreatic islet transplantation. Cell Transplant. 13(7-8):833-838; 2004.
7. Bartholomew, A.; Sher, D.; Sosler, S.; Stock, W.; Lazda, V.; Koshy, M.; Devine, S.; vanBesien, K. Stem cell transplantation eliminates alloantibody in a highly sensitized patient. Transplantation 72(10):1653-1655; 2001.
8. Baskin, G. B. Disseminated cytomegalovirus infection in immunodeficient rhesus monkeys. Am. J. Pathol. 129(2):345-352; 1987.
9. Berger, N.; Wirmsberger, R.; Kafka, R.; Margreiter, C.; Ebenbichler, C.; Stelzmueller, I.; Margreiter, R.; Steurer, W.; Mark, W.; Bonatti, H. Infectious complications following 72 consecutive enteric-drained pancreas transplants. Transpl. Int. 19(7):549-557; 2006.
10. Berman, D. M.; Cabrera, O.; Kenyon, N. M.; Miller, J.; Tam, S. H.; Khandekar, V. S.; Picha, K. M.; Soderman, A. R.; Jordan, R. E.; Bugelski, P. J.; Horninger, D.; Lark, M.; Davis, J. E.; Alejandro, R.; Berggren, P. O.; Zimmerman, M.; O'Neil, J. J.; Ricordi, C.; Kenyon, N. S. Interference with tissue factor prolongs intrahepatic islet allograft survival in a nonhuman primate marginal mass model. Transplantation 84(3):308-315; 2007.
11. Biron, K. K. Antiviral drugs for cytomegalovirus diseases. Antiviral Res. 71(2-3):154-163; 2006.
12. Cardona, K.; Korbutt, G. S.; Milas, Z.; Lyon, J.; Cano, J.; Jiang, W.; Bello-Laborn, H.; Hacquoil, B.; Strobert, E.; Gangappa, S.; Weber, C. J.; Pearson, T. C.; Rajotte, R. V.; Larsen, C. P. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat. Med. 12(3):304-306; 2006.
13. Carstens, J.; Andersen, H. K.; Spencer, E.; Madsen, M. Cytomegalovirus infection in renal transplant recipients. Transpl. Infect. Dis. 8(4):203-212; 2006.
14. Castagnola, E.; Cappelli, B.; Erba, D.; Rabagliati, A.; Lanino, E.; Dini, G. Cytomegalovirus infection after bone marrow transplantation in children. Hum. Immunol. 65(5):416-422; 2004.
15. Castro, S. M.; Sporleder, H.; Schroeder, R.; Santos, A.; Garcia, V.; Neumann, J.; Costa, S. C. Lymphocyte subpopulations during cytomegalovirus disease in renal transplant recipients. Braz. J. Med. Biol. Res. 36(6):795-805; 2003.
16. Cure, P.; Pileggi, A.; Faradji, R. N.; Baidal, D. A.; Froud, T.; Selvaggi, G.; Ricordi, C.; Alejandro, R. Cytomegalovirus infection in a recipient of solitary allogeneic islets. Am. J. Transplant. 6(5 Pt. 1):1089-1090; 2006.
17. Eckhard, M.; Martin, I.; Eich, T.; Weimer, R.; Zinn, S.; Bretzel, R. G.; Brendel, M. D. Incidence of cytomegalovirus infections after immunosuppression induction in clinical islet transplantation and impact on graft function. Transplant. Proc. 34(5):1922-1924; 2002.
18. Essa, S.; Pacsa, A. S.; Raghupathy, R.; Al-Attiyah, R.; El-Shazly, A.; Said, T. CD4(+) T cell levels are decreased during active CMV infection in kidney transplant recipients. FEMS Immunol. Med. Microbiol. 34(1):17-22; 2002.
19. Froud, T.; Ricordi, C.; Baidal, D. A.; Hafiz, M. M.; Ponte, G.; Cure, P.; Pileggi, A.; Poggioli, R.; Ichii, H.; Khan, A.; Ferreira, J. V.; Pugliese, A.; Esquenazi, V. V.; Kenyon, N. S.; Alejandro, R. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am. J. Transplant. 5(8):2037-2046; 2005.
20. Gandhi, M. K.; Khanna, R. Human cytomegalovirus: Clinical aspects, immune regulation, and emerging treatments. Lancet Infect. Dis. 4(12):725-738; 2004.
21. Gerard, L.; Leport, C.; Flandre, P.; Houhou, N.; Salmon-Ceron, D.; Pepin, J. M.; Mandet, C.; Brun-Vezinet, F.; Vilde, J. L. Cytomegalovirus (CMV) viremia and the CD4+ lymphocyte count as predictors of CMV disease in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 24(5):836-840; 1997.
22. Goeckeler, W. F.; Edwards, B.; Volkert, W. A.; Holmes, R. A.; Simon, J.; Wilson, D. Skeletal localization of samarium-153 chelates: Potential therapeutic bone agents. J. Nucl. Med. 28(4):495-504; 1987.
23. Guo, Z.; Wu, T.; Sozen, H.; Pan, Y.; Heuss, N.; Kalscheuer, H.; Sutherland, D. E.; Blazar, B. R.; Hering, B. J. A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic NOD mice. Transplantation 75(7):909-915; 2003.
24. Hafiz, M. M.; Poggioli, R.; Caulfield, A.; Messinger, S.; Geiger, M. C.; Baidal, D. A.; Froud, T.; Ferreira, J. V.; Tzakis, A. G.; Ricordi, C.; Alejandro, R. Cytomegalovirus prevalence and transmission after islet allograft transplant in patients with type 1 diabetes mellitus. Am. J. Transplant. 4(10):1697-1702; 2004.
25. Han, D.; Xu, X.; Pastori, R. L.; Ricordi, C.; Kenyon, N. S. Elevation of cytotoxic lymphocyte gene expression is predictive of islet allograft rejection in nonhuman primates. Diabetes 51(3):562-566; 2002.
26. Hardinger, K. L.; Schnitzler, M. A.; Koch, M. J.; Labile, E.; Stirnemann, P. M.; Miller, B.; Enkvetchakul, D.; Brennan, D. C. Thymoglobulin induction is safe and effective in live-donor renal transplantation: A single center experience. Transplantation 81(9):1285-1289; 2006.
27. Hastings, M. C.; Wyatt, R. J.; Lau, K. K.; Jones, D. P.; Powell, S. L.; Hays, D. W.; Gaber, L. W.; Gaber, A. O.; Ault, B. H. Five years' experience with thymoglobulin induction in a pediatric renal transplant population. Pediatr. Transplant. 10(7):805-810; 2006.
28. Haustein, S. V.; Kolterman, A. J.; Sundblad, J. J.; Fechner, J. H.; Knechtle, S. J. Nonhuman primate infections after organ transplantation. ILAR J. 49(2):209-219; 2008.
29. Hecht, G.; Eventov-Friedman, S.; Rosen, C.; Shezen, E.; Tchorsh, D.; Aronovich, A.; Freud, E.; Golan, H.; El-Hasid, R.; Katchman, H.; Hering, B. J.; Zung, A.; Kra-Oz, Z.; Shaked-Mishan, P.; Yusim, A.; Shtabsky, A.; Idelevitch, P.; Tobar, A.; Harmelin, A.; Bachar-Lustig, E.; Reisner, Y. Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model. Proc. Natl. Acad. Sci. USA 106(21):8659-8664; 2009.
30. Hering, B. J.; Wijkstrom, M.; Graham, M. L.; Hardstedt, M.; Aasheim, T. C.; Jie, T.; Ansite, J. D.; Nakano, M.; Cheng, J.; Li, W.; Moran, K.; Christians, U.; Finnegan, C.; Mills, C. D.; Sutherland, D. E.; Bansal-Pakala, P.; Murtaugh, M. P.; Kirchhof, N.; Schuurman, H. J. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed non-human primates. Nat. Med. 12(3):301-303; 2006.
31. Ho, M. Human cytomegalovirus in immunosuppressed patients. In: Ho, M., ed. Cytomegalovirus biology and infection, 2nd ed. New York: Plenum; 1991:249-299.
32. Hodson, E. M.; Barclay, P. G.; Craig, J. C.; Jones, C.; Kable, K.; Strippoli, G. F.; Vimalachandra, D.; Webster, A. C. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst. Rev. 4:CD003774; 2005.
33. Huff, J. L.; Eberle, R.; Capitanio, J.; Zhou, S. S.; Barry, P. A. Differential detection of B virus and rhesus cytomegalovirus in rhesus macaques. J. Gen. Virol. 84(Pt. 1):83-92; 2003.
34. Inverardi, L.; Linetsky, E.; Pileggi, A.; Molano, R. D.; Serafini, A.; Paganelli, G.; Ricordi, C. Targeted bone marrow radioablation with 153Samarium-lexidronam promotes allogeneic hematopoietic chimerism and donor-specific immunologic hyporesponsiveness. Transplantation 77(5):647-655; 2004.
35. Jonker, M.; Ringers, J.; Kuhn, E. M.; Hart, B.; Foulkes, R. Treatment with anti-MHC-class-II antibody postpones kidney allograft rejection in primates but increases the risk of CMV activation. Am. J. Transplant. 4(11):1756-1761; 2004.
36. Kaur, A.; Hale, C. L.; Noren, B.; Kassis, N.; Simon, M. A.; Johnson, R. P. Decreased frequency of cytomegalovirus (CMV)-specific CD4+ T lymphocytes in simian immunodeficiency virus-infected rhesus macaques: Inverse relationship with CMV viremia. J. Virol. 76(8):3646-3658; 2002.
37. Kenyon, N. S.; Chatzipetrou, M.; Masetti, M.; Ranuncoli, A.; Oliveira, M.; Wagner, J. L.; Kirk, A. D.; Harlan, D. M.; Burkly, L. C.; Ricordi, C. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc. Natl. Acad. Sci. USA 96(14):8132-8137; 1999.
38. Ljungman, P.; Griffiths, P.; Paya, C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin. Infect. Dis. 34(8):1094-1097; 2002.
39. Lo, A.; Stratta, R. J.; Egidi, M. F.; Shokouh-Amiri, M. H.; Grewal, H. P.; Kisilisik, A. T.; Trofe, J.; Alloway, R. R.; Gaber, L. W.; Gaber, A. O. Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis. Transpl. Infect. Dis. 3(1):8-15; 2001.
40. Mueller, N. J.; Barth, R. N.; Yamamoto, S.; Kitamura, H.; Patience, C.; Yamada, K.; Cooper, D. K.; Sachs, D. H.; Kaur, A.; Fishman, J. A. Activation of cytomegalovirus in pig-to-primate organ xenotransplantation. J. Virol. 76(10):4734-4740; 2002.
41. Nehlsen-Cannarella, S. L.; Bohn, M. L. A direct approach to determine the ABH phenotype of baboons. Immunol. Invest. 16(1):57-62; 1987.
42. Nguyen, Q.; Champlin, R.; Giralt, S.; Rolston, K.; Raad, I.; Jacobson, K.; Ippoliti, C.; Hecht, D.; Tarrand, J.; Luna, M.; Whimbey, E. Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients. Clin. Infect. Dis. 28(3):618-623; 1999.
43. Osarogiagbon, R. U.; Defor, T. E.; Weisdorf, M. A.; Erice, A.; Weisdorf, D. J. CMV antigenemia following bone marrow transplantation: Risk factors and outcomes. Biol. Blood Marrow Transplant. 6(3):280-288; 2000.
44. Pearson, T. C.; Trambley, J.; Odom, K.; Anderson, D. C.; Cowan, S.; Bray, R.; Lin, A.; Hollenbaugh, D.; Aruffo, A.; Siadak, A. W.; Strobert, E.; Hennigar, R.; Larsen, C. P. Anti-CD40 therapy extends renal allograft survival in rhesus macaques. Transplantation 74(7):933-940; 2002.
45. Reischig, T.; Jindra, P.; Hes, O.; Svecova, M.; Klaboch, J.; Treska, V. Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation. Am. J. Transplant. 8(1):69-77; 2008.
46. Ricordi, C.; Lacy, P. E.; Finke, E. H.; Olack, B. J.; Scharp, D. W. Automated method for isolation of human pancreatic islets. Diabetes 37(4):413-420; 1988.
47. Rowbottom, A. W.; Lepper, M. W.; Sharpstone, D.; Gazzard, B. Cytomegalovirus (CMV) infection in AIDS patients is associated with a CD3 receptor-mediated T cell hyporesponsiveness. Clin. Exp. Immunol. 111(3):559-563; 1998.
48. Schmitz, J. E.; Simon, M. A.; Kuroda, M. J.; Lifton, M. A.; Ollert, M. W.; Vogel, C. W.; Racz, P.; Tenner-Racz, K.; Scallon, B. J.; Dalesandro, M.; Ghrayeb, J.; Rieber, E. P.; Sasseville, V. G.; Reimann, K. A. A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody. Am. J. Pathol. 154(6):1923-1932; 1999.
49. Shapiro, A. M.; Lakey, J. R.; Ryan, E. A.; Korbutt, G. S.; Toth, E.; Warnock, G. L.; Kneteman, N. M.; Rajotte, R. V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343(4):230-238; 2000.
50. Shorvon, S. D.; Lowenthal, A.; Janz, D.; Bielen, E.; Loiseau, P. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group. Epilepsia 41(9):1179-1186; 2000.
51. Snydman, D. R. The case for cytomegalovirus prophylaxis in solid organ transplantation. Rev. Med. Virol. 16(5):289-295; 2006.
52. Swack, N. S.; Hsiung, G. D. Natural and experimental simian cytomegalovirus infections at a primate center. J. Med. Primatol. 11(3):169-177; 1982.
53. Taira, M.; Inaba, M.; Takada, K.; Baba, S.; Fukui, J.; Ueda, Y.; Kwon, A. H.; Hisha, H.; Kamiyama, Y.; Ikehara, S. Treatment of streptozotocin-induced diabetes mellitus in rats by transplantation of islet cells from two major histocompatibility complex disparate rats in combination with intra bone marrow injection of allogeneic bone marrow cells. Transplantation 79(6):680-687; 2005.
54. Tsai, J. J.; Yen, D. J.; Hsih, M. S.; Chen, S. S.; Hiersemenzel, R.; Edrich, P.; Lai, C. W. Efficacy and safety of levetiracetam (up to 2000 mg/day) in Taiwanese patients with refractory partial seizures: A multicenter, randomized, double-blind, placebo-controlled study. Epilepsia 47(1):72-81; 2006.
55. Turner, J. H.; Claringbold, P. G.; Berger, J. D.; Martindale, A. A.; Glancy, J. R. 153Sm-EDTMP and melphalan chemoradiotherapy regimen for bone marrow ablation prior to marrow transplantation: An experimental model in the rat. Nucl. Med. Commun. 13(5):321-329; 1992.
56. van Besien, K.; Bartholomew, A.; Stock, W.; Peace, D.; Devine, S.; Sher, D.; Sosman, J.; Chen, Y. H.; Koshy, M.; Hoffman, R. Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease. Bone Marrow Transplant. 26(4):445-449; 2000.
57. Vogel, P.; Weigler, B. J.; Kerr, H.; Hendrickx, A. G.; Barry, P. A. Seroepidemiologic studies of cytomegalovirus infection in a breeding population of rhesus macaques. Lab. Anim. Sci. 44(1):25-30; 1994.
58. Warnock, G. L.; Kneteman, N. M.; Ryan, E. A.; Rabinovitch, A.; Rajotte, R. V. Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35(1):89-95; 1992.
59. Yakubovich, N.; Fung, M. A.; Thompson, D. M. Three cases of cytomegalovirus infection following pancreatic islet transplantation. Transplant. Proc. 39(5):1599-1603; 2007.